Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Albumin Market by Products (Human Serum, Bovine Serum, Recombinant), By Application (Therapeutics, Drug Formulation & Vaccine, Component of Media) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Albumin Market was valued at USD 5.43 Billion in the year 2017. Global Albumin Market is further estimated to grow at a CAGR of 9.28% from 2018 to reach USD 9.25 Billion by the year 2023.

Grifols S.A. (Grifols International, S.A.) (Spain), Merck KGaA (U.S), Novozymes A/S (Albumedix Ltd.) (Denmark), CSL Limited Behring LLC (U.S.), Thermo Fisher Scientific Inc. (Affymetrix, Inc.) (U.S), Baxter International Inc. (U.S.), China Biologic Products Holdings, Inc. (China), Octapharma AG (Switzerland),Sigma-Aldrich Corporation (U.S) and Celgene (U.S) are some of the key players in the global Albumin Market. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

North America region holds the highest market share in 2017 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, China, Japan, and Indonesia are the major markets in Asia Pacific region and holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years. Asia-Pacific is anticipated to dominate the market during the analysis period, owing to high population base, increase in disposable income, and improvement in patient awareness about albumin products.

Drivers:

            Increase in prevalence of rare diseases and various life-threatening conditions

            Growing demand for albumin and plasma collection

Restraints:

            Limited Reimbursement and stringent regulations

            Various risks associated with the use of albumin

Opportunities:

            Developing economies and investments in emerging regions

Challenges:

            High Competition from Substitute Products

The global Albumin market is segmented on the basis of mode of product, by application and by region. On the basis of product, the market is segmented as Human Serum Albumin, Bovine Serum Albumin and Recombinant Albumin of which Human Serum Albumin segment is expected to hold the highest market share during the forecast period and are expected to grow with highest CAGR.

On the basis of application, the market is segmented as Therapeutics, Drug Formulation & Vaccine, Component of Media and Other Applications in which Therapeutics application segment holds the highest market share in the forecasted period.

Key Benefits for Stakeholders

Albumin product manufacturers and distributors

Pharmaceutical and biotechnology companies

Hospitals and healthcare clinics

Research and Consulting organization

Government agencies & authorities

By Product

Human Serum Albumin

Bovine Serum Albumin

Recombinant Albumin

By Application

Therapeutics

Drug Formulation & Vaccine

Component of Media

Other Applications

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Grifols S.A. (Grifols International, S.A.)

Merck KGaA

Novozymes A/S (Albumedix Ltd.)

CSL Limited

Thermo Fisher Scientific Inc. (Affymetrix, Inc.)

Baxter International Inc.

China Biologic Products Holdings, Inc.

Octapharma AG

Sigma-Aldrich Corporation

Celgene 

(Another brief information of 10 companies will be provided in the report)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Albumin Market, by product

6.1 Human Serum Albumin

6.2 Bovine Serum Albumin

6.3 Recombinant Albumin

7. Global Albumin Market, By Application

7.1 Therapeutics

7.2 Drug Formulation & Vaccine

7.3 Component of Media

7.4 Other Applications

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 Grifols S.A. (Grifols International, S.A.)

9.2 Merck KGaA

9.3 Novozymes A/S (Albumedix Ltd.)

9.4 CSL Limited

9.5 Thermo Fisher Scientific Inc. (Affymetrix, Inc.)

9.6 Baxter International Inc.

9.7 China Biologic Products Holdings, Inc.

9.8 Octapharma AG

9.9 Sigma-Aldrich Corporation

9.10 Celgene 

(Another brief information of 10 companies will be provided in the report)

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

 

List of Tables (14 Tables)

 

Table 01: Global Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017–2023
Table 02: Global Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2023
Table 03: Global Albumin Market Size (US$ Mn) Forecast, by Region, 2017-2023
Table 04: North America Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2023
Table 05: North America Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2023
Table 06: North America Albumin Market Value (US$ Mn) Forecast, by Country, 2017-2023
Table 07: Europe Albumin Market Value (US$ Mn) Forecast, by Product, 2017-2023
Table 08: Europe Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2023
Table 09: Europe Albumin Market Value (US$ Mn) Forecast, by Country, 2017-2023
Table 10: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2023
Table 11: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2023
Table 12: Asia Pacific Albumin Market Value (US$ Mn) Forecast, by Country, 2017-2023
Table 13: Rest of the World Albumin Market Value (US$ Mn) Forecast, by Product Type, 2017-2023
Table 14: Rest of the World Albumin Market Value (US$ Mn) Forecast, by Application, 2017-2023

 

List of Figures (52 Figures)

Figure 01: Global Albumin Market Size, by Product Type (US$ Mn), 2017
Figure 02: Global Albumin Market Share, by Application (% Share), 2017
Figure 03: Albumin market Top trends and drivers
Figure 04: Market Share analysis, by Region
Figure 05: Major drivers of albumin market, by Region
Figure 06: Market Opportunity Map
Figure 07: Key Industry Events
Figure 08: Global Albumin Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2023
Figure 09: Market Value Share, by Product Type (2017)
Figure 10: Market Value Share, by Application (2017)
Figure 11: Market Value Share, by Region (2017)
Figure 12: Porter’s Analysis, Albumin Market
Figure 13: Global Albumin Market Value Share Analysis, by Product Type, 2017 and 2023
Figure 14: Global Human Serum Albumin Market Revenue (US$ Mn), 2017-2023
Figure 15: Global Bovine Serum Albumin Market Revenue (US$ Mn), 2017-2023
Figure 16: Global Recombinant Albumin Market Revenue (US$ Mn), 2017-2023
Figure 17: Global Albumin Market Attractiveness Analysis, by Product Type
Figure 18: Global Albumin Market Value Share Analysis, by Application, 2017  and 2023
Figure 19: Global Albumin as Blood Volumizer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2023
Figure 20: Global Albumin for Drug Formulation and Vaccines Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2023
Figure 21: Global Albumin for Life Sciences Market Revenue (US$ Mn), 2017-2023
Figure 22: Global Albumin for Other Application Market Revenue (US$ Mn), 2017-2023
Figure 23: Global Albumin Market Attractiveness Analysis, by Application
Figure 24: Global Albumin Market Snapshot, by Country 
Figure 25: Global Albumin Market Value Share Analysis, by Region, 2017and 2023
Figure 26: Global Albumin Market Attractiveness Analysis, by Region
Figure 27: North America Albumin Market Size (US$ Mn) Forecast, 2017-2023
Figure 28: North America Market Attractiveness Analysis, by Country
Figure 29: North America Albumin Market Value Share Analysis, by Product Type, 2017and 2023
Figure 30: North America Albumin Market Value Share Analysis, by Application, 2017and 2023
Figure 31: North America Albumin Market Value Share Analysis, by Country, 2017and 2023
Figure 32: North America Albumin Market Attractiveness Analysis, by Product
Figure 33: North America Albumin Market Attractiveness Analysis, by Application
Figure 34: Europe Albumin Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection, 2017-2023
Figure 35: Europe Albumin Market Attractiveness Analysis, by Country
Figure 36: Europe Albumin Market Value Share Analysis, by Product, 2017and 2023
Figure 37: Europe Albumin Market Value Share Analysis, by Application, 2017and 2023
Figure 38: Europe Albumin Market Value Share Analysis, by Country, 2017and 2023
Figure 39: Europe Albumin Market Attractiveness Analysis, by Product 
Figure 40: Europe Albumin Market Attractiveness Analysis, by Application
Figure 41: Asia Pacific Albumin Market Size (US$ Mn) Forecast, 2017-2023
Figure 42: Asia Pacific Market Attractiveness Analysis, by Country
Figure 43: Asia Pacific Albumin Market Value Share Analysis, by Product Type, 2017and 2023
Figure 44: Asia Pacific Albumin Market Value Share Analysis, by Application, 2017and 2023
Figure 45: Asia Pacific Albumin Market Value Share Analysis, by Country, 2017and 2023
Figure 46: Asia Pacific Albumin Market Attractiveness Analysis, by Product 
Figure 47: Asia Pacific Albumin Market Attractiveness Analysis, by Application
Figure 48: Rest of the World Albumin Market Size (US$ Mn) Forecast, 2017-2023
Figure 49: Rest of the World Albumin Market Value Share Analysis, by Product Type, 2017and 2023
Figure 50: Rest of the World Albumin Market Value Share Analysis, by Application, 2017 and 2023
Figure 51: Rest of the World Albumin Market Attractiveness Analysis, by Product 
Figure 52: Rest of the World Albumin Market Attractiveness Analysis, by Application

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports